Effect of chloroquine and leupeptin on intracellular accumulation of amyloid‐beta (Aβ) 1–42 peptide in a murine N9 microglial cell line
暂无分享,去创建一个
G. Cole | S. Frautschy | Fusheng Yang | T. Chu | F. Yang | Thuy Tran | W. Beech | T. Tran
[1] R. Ludwig,et al. Proteolytic Degradation of Alzheimer's Disease Amyloid β‐Peptide by a Metalloproteinase from Microglia Cells , 1998, Journal of neurochemistry.
[2] F. Maxfield,et al. Slow Degradation of Aggregates of the Alzheimer’s Disease Amyloid β-Protein by Microglial Cells* , 1997, The Journal of Biological Chemistry.
[3] D. Selkoe,et al. Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural Cells* , 1997, The Journal of Biological Chemistry.
[4] C. Glabe,et al. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells , 1997, Brain Research.
[5] H. Hamazaki. Cathepsin D is involved in the clearance of Alzheimer's β‐amyloid protein , 1996 .
[6] C. Masters,et al. Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells , 1996, FEBS letters.
[7] J. Mcdermott,et al. Degradation of Alzheimer's beta-amyloid protein by human cathepsin D. , 1996, Neuroreport.
[8] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[9] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[10] D. Mann,et al. Colocalization of Lysosomal Hydrolase and β-Amyloid in Diffuse Plaques of the Cerebellum and Striatum in Alzheimer's Disease and Down's Syndrome , 1996, Journal of neuropathology and experimental neurology.
[11] G. Cole,et al. Scavenging of Alzheimer's amyloid β‐protein by microglia in culture , 1996, Journal of neuroscience research.
[12] R. Nixon,et al. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] H. Nakanishi,et al. Age-related changes in cellular localization and enzymatic activities of cathepsins B, L and D in the rat trigeminal ganglion neuron , 1995, Mechanisms of Ageing and Development.
[14] S. Younkin,et al. Amyloid β protein (Aβ) removal by neuroglial cells in culture , 1995, Neurobiology of Aging.
[15] D. Quon,et al. -Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells (*) , 1995, The Journal of Biological Chemistry.
[16] H. Vinters,et al. Monoclonal antibody to the C‐terminus of β‐amyloid , 1994 .
[17] T. Iwatsubo,et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.
[18] R. Nixon,et al. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.
[19] D. Selkoe,et al. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide , 1993, Cell.
[20] M J Ball,et al. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. Ricciardi-Castagnoli,et al. Inducible nitric oxide synthase activity of cloned murine microglial cells , 1993, Glia.
[22] J. Hardy,et al. A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene , 1992, Nature Genetics.
[23] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[24] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[25] C. Glabe,et al. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[27] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[28] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[29] R. Nixon,et al. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Mann,et al. EARLY SENILE PLAQUES IN DOWN'S SYNDROME BRAINS SHOW A CLOSE RELATIONSHIP WITH CELL BODIES OF NEURONS , 1989, Neuropathology and applied neurobiology.
[31] D. Selkoe,et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.
[32] R. Salgia,et al. Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible. , 1987, The Journal of biological chemistry.
[33] P. Seglen,et al. Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes. , 1980, Biochimica et biophysica acta.
[34] P. Seglen. Inhibitors of lysosomal function. , 1983, Methods in enzymology.